| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FCX | Common Stock | Options Exercise | $232,050 | +7,500 | +13% | $30.94 | 67,337 | 08 Nov 2021 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $189,800 | +10,000 | +15% | $18.98 | 77,337 | 08 Nov 2021 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $36,975 | +8,500 | +11% | $4.35* | 85,837 | 08 Nov 2021 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $131,920 | +8,500 | +9.9% | $15.52 | 94,337 | 08 Nov 2021 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $187,400 | +10,000 | +11% | $18.74 | 104,337 | 08 Nov 2021 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $787,725 | +22,500 | +22% | $35.01 | 126,837 | 08 Nov 2021 | Direct | |
| transaction | FCX | Common Stock | Sale | $2,619,673 | -67,000 | -53% | $39.10 | 59,837 | 08 Nov 2021 | Direct | F4, F5 |
| holding | FCX | Common Stock | 1,959 | 08 Nov 2021 | Through 401(k) Plan | F1 | |||||
| holding | FCX | Common Stock | 3,785 | 08 Nov 2021 | By Spouse, through GRAT | ||||||
| holding | FCX | Common Stock | 3,785 | 08 Nov 2021 | Through GRAT |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FCX | Options (right to buy) | Options Exercise | $0 | -22,500 | -82% | $0.000000 | 5,000 | 08 Nov 2021 | Common Stock | 22,500 | $35.01 | Direct | F2 |
| transaction | FCX | Options (right to buy) | Options Exercise | $0 | -7,500 | -60% | $0.000000 | 5,000 | 08 Nov 2021 | Common Stock | 7,500 | $30.94 | Direct | F2 |
| transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -8,500 | -18% | $0.000000 | 38,500 | 08 Nov 2021 | Common Stock | 8,500 | $4.35 | Direct | F2 |
| transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -8,500 | -34% | $0.000000 | 16,500 | 08 Nov 2021 | Common Stock | 8,500 | $15.52 | Direct | F2 |
| transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -10,000 | -29% | $0.000000 | 25,000 | 08 Nov 2021 | Common Stock | 10,000 | $18.74 | Direct | F3 |
| transaction | FCX | Options (right to buy) | Options Exercise | $0 | -10,000 | -50% | $0.000000 | 10,000 | 08 Nov 2021 | Common Stock | 10,000 | $18.98 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Based on plan statement as of December 31, 2020. |
| F2 | 25% exercisable on the date indicated and 25% exercisable on each of the next three anniversaries thereof. |
| F3 | 33.3% exercisable on the date indicated and on each of the next two anniversaries thereof. |
| F4 | Amount beneficially owned following the reported transactions includes 44,999 Common Stock Restricted Stock Units. |
| F5 | The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $39.0300 - $39.1750. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |